Literature DB >> 34154888

NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia.

Yannan Zhang1, Huanzhen Zhang2, Shengzhong Rong3, Cailing Bian4, Yuexin Yang5, Hongzhi Pan6.   

Abstract

BACKGROUND AND AIMS: Hyperuricemia (HUA) were associated with Metabolic syndrome (MetS) and its components. However, the molecular mechanism of uric acid in the development of MetS was not well elucidated. The aim of this study was developing a systemic metabolic profile by using metabolomics approach to explore the molecular mechanism of uric acid in the development of MetS. METHODS AND
RESULTS: Anthropometric, clinical biochemical data, and serum samples were collected from patients with MetS, MetS combined with HUA (MetS & HUA) and healthy controls. 1H nuclear magnetic resonance (NMR) spectroscopy was used to detect endogenous small molecule metabolites of serum samples, then multivariate statistical analysis was applied to distinguish samples of different groups. In addition, pathway analysis was performed to contribute to understanding the metabolic change. By serum metabolic profiling, a total of 20 identified metabolites including lipids, amino acids, and organic acids were significantly altered in MetS and MetS & HUA patients. MetS & HUA patients presented a more severe disorder in both identified metabolites and BMI and biochemical indexes. According to pathway analysis, there were 3 and 5 metabolic pathways remarkably perturbed in MetS and MetS & HUA group respectively.
CONCLUSION: Taken together, we identified disordered metabolites and related pathways for both MetS and MetS & HUA patients, and found a more severe metabolic disorder in MetS patients who has a higher serum uric acid. Our study provides biochemical insights into the metabolic alteration for the progress of MetS.
Copyright © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hyperuricemia; Metabolic syndrome; Metabolites; Metabolomics; NMR; Serum uric acid

Year:  2021        PMID: 34154888     DOI: 10.1016/j.numecd.2021.05.015

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS.

Authors:  Leen Oyoun Alsoud; Nelson C Soares; Hamza M Al-Hroub; Muath Mousa; Violet Kasabri; Nailya Bulatova; Maysa Suyagh; Karem H Alzoubi; Waseem El-Huneidi; Bashaer Abu-Irmaileh; Yasser Bustanji; Mohammad H Semreen
Journal:  Metabolites       Date:  2022-06-01

2.  Anti-Gout Effects of the Medicinal Fungus Phellinus igniarius in Hyperuricaemia and Acute Gouty Arthritis Rat Models.

Authors:  Hongxing Li; Xinyue Zhang; Lili Gu; Qín Li; Yue Ju; Xuebin Zhou; Min Hu; Qīn Li
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

3.  A simple prediction model of hyperuricemia for use in a rural setting.

Authors:  Jia-Cheng Shi; Xiao-Huan Chen; Qiong Yang; Cai-Mei Wang; Qian Huang; Yan-Ming Shen; Jian Yu
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

4.  Impact of a long-term high-fructose diet on systemic metabolic profiles of mice.

Authors:  Changmeng Cui; Changshui Wang; Shasha Han; Dingyi Yu; Li Zhu; Pei Jiang
Journal:  FASEB Bioadv       Date:  2022-05-16

5.  Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics.

Authors:  Nankun Qin; Ming Qin; Wenjun Shi; Lingbo Kong; Liting Wang; Guang Xu; Yuying Guo; Jiayu Zhang; Qun Ma
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.